Karen L. Smith Aurinia Pharmaceuticals Inc. (AUPH) insider trading activity

AUPH Quotes by TradingView

Karen L. Smith is Director of Aurinia Pharmaceuticals Inc.. Currently has a direct ownership of 12,672 shares of AUPH, which is worth approximately $111,133. The most recent transaction as insider was on Nov 11, 2024, when has been sold 5,241 shares (Common Stock) at a price of $8.43 per share, resulting in proceeds of $44,181. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 12.7K
n/a 3M change
n/a 12M change
Total Value Held $111,133

Karen L. Smith Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 11 2024
SELL
Open market or private sale
$44,181 $8.43 p/Share
5,241 Reduced 29.26%
12,672 Common Stock
Nov 08 2024
BUY
Exercise of conversion of derivative security
-
17,913 Added 50.0%
17,913 Common Stock

Also insider at

XLRN
ACCELERON PHARMA INC Healthcare
Director
EBS
Emergent BioSolutions Inc. Healthcare
EVP, Chief Medical Officer
SGMO
SANGAMO THERAPEUTICS, INC Healthcare
TALS
Talaris Therapeutics, Inc. Healthcare
Director
CRTX
Cortexyme, Inc. Healthcare
Chief Medical Officer
SKYE
Skye Bioscience, Inc. Healthcare
Director
CNTX
Context Therapeutics Inc. Healthcare
Director
KLS

Karen L. Smith

Director
Gaithersburg,, MD

Track Institutional and Insider Activities on AUPH

Follow Aurinia Pharmaceuticals Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AUPH shares.

Notify only if

Insider Trading

Get notified when an Aurinia Pharmaceuticals Inc. insider buys or sells AUPH shares.

Notify only if

News

Receive news related to Aurinia Pharmaceuticals Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on AUPH